Key statistics
On Monday, Clarity Pharmaceuticals Ltd (CU6:ASX) closed at 7.48, -16.66% below its 52-week high of 8.98, set on Sep 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.29 |
---|---|
High | 7.60 |
Low | 7.29 |
Bid | 7.45 |
Offer | 7.48 |
Previous close | 7.20 |
Average volume | 985.70k |
---|---|
Shares outstanding | 320.21m |
Free float | 231.02m |
P/E (TTM) | -- |
Market cap | 2.31bn AUD |
EPS (TTM) | -0.1541 AUD |
Data delayed at least 20 minutes, as of Nov 11 2024 05:10 GMT.
More ▼
- Copper-67 SAR-bisPSMA updates
- Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer
- SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort
- Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA